title: Bioenergetics in diabetic neuropathy: what we need to know.
abstract: Progress in developing treatments for diabetic neuropathy is slowed by our limited understanding of how disturbances in metabolic substrates - glucose and fatty acids - produce nerve injury. In this review, we present the current oxidative stress hypothesis and experimental data that support it. We identify weaknesses in our understanding of diabetes-disordered metabolism in the neurovascular unit, that is, in critical cell types of the microvascular endothelium, peripheral sensory neurons, and supporting Schwann cells. Greater understanding of peripheral nervous system bioenergetics may provide insight into new drug therapies or improvements in dietary interventions in diabetes or even pre-diabetes.
authors.affiliation: Department of Neurology, University of Michigan, Ann Arbor, MI 48109, USA.
authors.forename: Lucy M
authors.initials: LM
authors.lastname: Hinder
authors.forename: Andrea M
authors.initials: AM
authors.lastname: Vincent
authors.forename: Charles F
authors.initials: CF
authors.lastname: Burant
authors.forename: Subramaniam
authors.initials: S
authors.lastname: Pennathur
authors.forename: Eva L
authors.initials: EL
authors.lastname: Feldman
mesh_terms: D000818:Animals; D003929:Diabetic Neuropathies / Q000378:metabolism* / Q000503:physiopathology*; D004734:Energy Metabolism / Q000502:physiology*; D006801:Humans